Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 279.00 | |
5 mg | In stock | $ 693.00 | |
10 mg | In stock | $ 988.00 | |
25 mg | In stock | $ 1,460.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,670.00 |
Description | CBHcy is a dual-substrate analogue, a specific BHMT inhibitor that causes betaine-homocysteine S-methyltransferase (BHMT) to adopt the same conformation as the ternary complex, potentially inducing the development of cysteinemia. |
Molecular Weight | 235.3 |
Formula | C9H17NO4S |
CAS No. | 88096-02-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CBHcy 88096-02-0 Metabolism Transferase inhibitor inhibit